Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, Mantle- Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00957736
What this trial is testing

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 252
Testing effectiveness (Phase 2)Active Not RecruitingNCT01661881
What this trial is testing

Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Christine Ryan 23
Not applicableLooking for participantsNCT05643235
What this trial is testing

Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors

Who this might be right for
Atrial FibrillationSupraventricular ArrhythmiaVentricular Arrhythmias and Cardiac Arrest+2 more
Northwell Health 50
Testing effectiveness (Phase 2)Study completedNCT00020943
What this trial is testing

Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 79
Testing effectiveness (Phase 2)Ended earlyNCT02413489
What this trial is testing

An Efficacy and Safety Proof of Concept Study of Daratumumab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma

Who this might be right for
Lymphoma, Mantle-CellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular
Janssen Research & Development, LLC 36
Testing effectiveness (Phase 2)Study completedNCT00377052
What this trial is testing

Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma

Who this might be right for
Lymphoma
NCIC Clinical Trials Group 29
Testing effectiveness (Phase 2)Study completedNCT00002461
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Montefiore Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT04703686
What this trial is testing

Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy

Who this might be right for
Diffuse Large B-Cell Lymphoma RefractoryRefractory Indolent Adult Non-Hodgkin LymphomaRefractory Transformed B-cell Non-Hodgkin Lymphoma+2 more
The Lymphoma Academic Research Organisation 67
Large-scale testing (Phase 3)Study completedNCT00003280
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma

Who this might be right for
Lymphoma
Swiss Cancer Institute 240
Testing effectiveness (Phase 2)Study completedNCT00719888
What this trial is testing

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+16 more
Fred Hutchinson Cancer Center 135
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Post-approval studies (Phase 4)Study completedNCT01180049
What this trial is testing

Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Pfizer 101
Not applicableStudy completedNCT04036448
What this trial is testing

A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma in Korea

Who this might be right for
Myelodysplastic SyndromesLymphoma, Mantle-CellLymphoma, Follicular
Celgene 28
Not applicableStudy completedNCT02652715
What this trial is testing

Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-Cell LymphomaAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma+29 more
Mayo Clinic 29
Testing effectiveness (Phase 2)Study completedNCT00238433
What this trial is testing

Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
OHSU Knight Cancer Institute 37
Early research (Phase 1)Study completedNCT00348985
What this trial is testing

PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+58 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT01397825
What this trial is testing

MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- Vincristine

Who this might be right for
Diffuse Large B-Cell LymphomaTransformed Follicular LymphomaMantle Cell Lymphoma+1 more
Millennium Pharmaceuticals, Inc. 45
Large-scale testing (Phase 3)Active Not RecruitingNCT02972840
What this trial is testing

BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL

Who this might be right for
Lymphoma, Mantle Cell
Acerta Pharma BV 635
Testing effectiveness (Phase 2)Study completedNCT02733042
What this trial is testing

Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LymphomaLeukemia, Lymphocytic, Chronic, B-Cell
Celgene 106
Testing effectiveness (Phase 2)Active Not RecruitingNCT04566887
What this trial is testing

Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
University Health Network, Toronto 105
Next Page